Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,981 to 2,000 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosome-based strategy for degenerative disease in orthopedics: Recent progress and perspectives. | J Orthop Translat | 2022 | 35891923 | PubTator, text mining | PubMed |
| The Role of RNA Modification in HIV-1 Infection. | Int J Mol Sci | 2022 | 35886919 | PubTator, text mining | PubMed |
| The Epitranscriptome in miRNAs: Crosstalk, Detection, and Function in Cancer. | Genes (Basel) | 2022 | 35886072 | PubTator, text mining | PubMed |
| RNA Modification in Inflammatory Bowel Diseases. | Biomedicines | 2022 | 35885000 | PubTator, text mining | PubMed |
| An Interplay between Epigenetics and Translation in Oocyte Maturation and Embryo Development: Assisted Reproduction Perspective. | Biomedicines | 2022 | 35884994 | PubTator, text mining | PubMed |
| m6A Regulator-Based Methylation Modification Patterns Characterized by Distinct Tumor Microenvironment Immune Profiles in Rectal Cancer. | Front Oncol | 2022 | 35875124 | PubTator, text mining | PubMed |
| The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | Front Cell Dev Biol | 2022 | 35874829 | PubTator, text mining | PubMed |
| Editorial: Multi-omics, Epigenomics, and Computational Analysis of Neurodegenerative Disorders. | Front Neurosci | 2022 | 35873823 | PubTator, text mining | PubMed |
| The m6A Methyltransferase METTL3 Ameliorates Methylglyoxal-Induced Impairment of Insulin Secretion in Pancreatic β Cells by Regulating MafA Expression. | Front Endocrinol (Lausanne) | 2022 | 35872977 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models. | Biomed Res Int | 2022 | 35872842 | PubTator, text mining | PubMed |
| PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA. | Oncogene | 2022 | 35869392 | PubTator, text mining | PubMed |
| m6A Topological Transition Coupled to Developmental Regulation of Gene Expression During Mammalian Tissue Development. | Front Cell Dev Biol | 2022 | 35865625 | PubTator, text mining | PubMed |
| Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells. | Front Oncol | 2022 | 35865470 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer. | BMC Cancer | 2022 | 35864471 | PubTator, text mining | PubMed |
| Lessons Learned and Yet-to-Be Learned on the Importance of RNA Structure in SARS-CoV-2 Replication. | Microbiol Mol Biol Rev | 2022 | 35862724 | PubTator, text mining | PubMed |
| Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma. | Front Oncol | 2022 | 35860559 | PubTator, text mining | PubMed |
| Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma. | Front Immunol | 2022 | 35860263 | PubTator, text mining | PubMed |
| Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35859893 | PubTator, text mining | PubMed |
| RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness. | Front Cell Dev Biol | 2022 | 35859892 | PubTator, text mining | PubMed |
| CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma. | Mol Cancer | 2022 | 35858900 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=100